Concord Story

<div class='circular--portrait' style='background:#FF01C9;color: #E6E6FA;font-size:4em;'>CM</div>
CCM -- USA Stock  

USD 3.82  0.17  4.26%

Concord Medical Current Ratio is relatively stable at the moment as compared to the past year. The company's current value of Current Ratio is estimated at 0.42. Sales per Share is expected to hike to 0.93 this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (241.1 M). As many millenniums are excited about healthcare space, it is only fair to summarize Concord Medical Services. I will take a closer look at this stock and the new sentiment generated by stakeholders. Here I will also expose some primary fundamental factors affecting Concord Medical's services, and outline how it will impact the outlook for investors this year.
Published over a month ago
View all stories for Concord Medical | View All Stories
Concord Medical (NYSE:CCM) continues to hike
Concord Medical Services reported the last year's revenue of 34.94 M. Reported Net Loss for the year was (47.22 M) with loss before taxes, overhead, and interest of (15.83 M).

How important is Concord Medical's Liquidity

Concord Medical financial leverage refers to using borrowed capital as a funding source to finance Concord Medical Services ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Concord Medical financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Concord Medical's total debt and its cash.

How Concord utilizes its cash?

To perform a cash flow analysis of Concord Medical, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Concord Medical is receiving and how much cash it distributes out in a given period. The Concord Medical cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Concord Medical Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (180.44 Million)

Is Concord Medical valued accurately by the market?

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Concord Medical has an asset utilization ratio of 0.97 percent. This denotes that the company is making $0.009702 for each dollar of assets. An increasing asset utilization means that Concord Medical Services is more efficient with each dollar of assets it utilizes for everyday operations.

Our take on today Concord Medical hike

The kurtosis is down to 54.57 as of today. Concord Medical Services is displaying above-average volatility over the selected time horizon. Investors should scrutinize Concord Medical Services independently to ensure intended market timing strategies are aligned with expectations about Concord Medical volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Concord Medical's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Concord Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

The Bottom Line

While few other entities within the medical care facilities industry are still a little expensive, even after the recent corrections, Concord Medical may offer a potential longer-term growth to stakeholders. With an impartial outlook on the current market volatility, it may be better to hold off any inventment activity and neither buy nor short any shares of Concord Medical at this time. The Concord Medical Services risk-reward trade off is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Concord Medical.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Concord Medical Services. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to